Plant-derived glucose transport inhibitors with potential antitumor activity.

Pratik Shriwas, Xiaozhuo Chen, A Douglas Kinghorn, Yulin Ren

Journal: Phytotherapy research : PTR 2020;34(5):1027-1040

PMID: 31823431

Abstract

Glucose, a key nutrient utilized by human cells to provide cellular energy and a carbon source for biomass synthesis, is internalized in cells via glucose transporters that regulate glucose homeostasis throughout the human body. Glucose transporters have been used as important targets for the discovery of new drugs to treat cancer, diabetes, and heart disease, owing to their abnormal expression during these disease conditions. Thus far, several glucose transport inhibitors have been used in clinical trials, and increasing numbers of natural products have been characterized as potential anticancer agents targeting glucose transport. The present review focuses on natural product glucose transport inhibitors of plant origin, including alkaloids, flavonoids and other phenolic compounds, and isoprenoids, with their potential antitumor properties also discussed.

© 2019 John Wiley & Sons, Ltd.

Address: Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio.; Department of Biological Sciences, Ohio University, Athens, Ohio.; Edison Biotechnology Institute, Ohio University, Athens, Ohio.; Molecular and Cellular Biology Program, Ohio University, Athens, Ohio.; Department of Biomedical Sciences, Ohio University, Athens, Ohio.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.